Name: Hereditary Tyrosinemia: Pathogenesis, Screening and Management (en Inglés)
SKU: 58567272
Price: 246.78 USD
Availability: InStock
Author: Tanguay, Robert M.
ISBN: 9783319857459

portada Hereditary Tyrosinemia: Pathogenesis, Screening and Management (en Inglés)

Hereditary Tyrosinemia: Pathogenesis, Screening and Management (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Tanguay, Robert M.

Idioma

Inglés

N° páginas

247

Encuadernación

Tapa Blanda

ISBN13

9783319857459

Categorías

Bioquímica
Biología molecular

Hereditary Tyrosinemia: Pathogenesis, Screening and Management (en Inglés)

Tanguay, Robert M. (Autor) · Springer · Tapa Blanda

Libro Nuevo Importado

Envío: 25 a 32 días háb.

$ 411.30$ 246.78

-40%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 246.78

Llega entre el 05 Oct y el 19 Oct a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Hereditary Tyrosinemia: Pathogenesis, Screening and Management (en Inglés)"

Hereditary tyrosinemia type 1 (HT1), the most severe inborn error of the tyrosine degradation pathway, is due to a deficiency in fumarylacetoacetate hydrolase (FAH). The worldwide frequency of HT1 is one per 100,000 births, but some regions have a significantly higher incidence (1:1,800). The FAH defect results in the accumulation of toxic metabolites, mainly in the liver. If left untreated, HT1 is usually fatal before the age of two. HT1 patients develop several chronic complications including cirrhosis with a high risk of hepatocellular carcinoma (HCC) and neuropsychological impairment. Treatment comprises an inhibitor of the pathway, Nitisinone, a strict dietary treatment or liver transplantation. Early treatment is important to avoid HCC. The book includes the latest developments on the molecular basis of HT1, its pathology, screening and diagnosis and management of the disease written by leading scientists, geneticists, hepatologists and clinicians in the field.